Orbimed Advisors as of June 30, 2018
Portfolio Holdings for Orbimed Advisors
Orbimed Advisors holds 142 positions in its portfolio as reported in the June 2018 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alexion Pharmaceuticals | 4.7 | $397M | 3.2M | 124.15 | |
| Biogen Idec (BIIB) | 4.0 | $339M | 1.2M | 290.24 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 4.0 | $334M | 2.0M | 169.96 | |
| Tricida | 3.9 | $326M | 11M | 29.90 | |
| Boston Scientific Corporation (BSX) | 3.7 | $313M | 9.6M | 32.70 | |
| Ascendis Pharma A S (ASND) | 3.5 | $294M | 4.4M | 66.52 | |
| Merck & Co (MRK) | 3.4 | $284M | 4.7M | 60.70 | |
| Allergan | 2.6 | $214M | 1.3M | 166.72 | |
| Celgene Corporation | 2.4 | $204M | 2.6M | 79.42 | |
| Jazz Pharmaceuticals (JAZZ) | 2.1 | $179M | 1.0M | 172.30 | |
| Wright Medical Group Nv | 2.0 | $164M | 6.3M | 25.96 | |
| Puma Biotechnology (PBYI) | 1.9 | $162M | 2.7M | 59.15 | |
| Clementia | 1.6 | $137M | 10M | 13.16 | |
| Mylan Nv | 1.6 | $134M | 3.7M | 36.14 | |
| Bristol Myers Squibb (BMY) | 1.6 | $132M | 2.4M | 55.34 | |
| Regeneron Pharmaceuticals (REGN) | 1.5 | $129M | 373k | 344.99 | |
| Aerie Pharmaceuticals | 1.5 | $127M | 1.9M | 67.55 | |
| Edwards Lifesciences (EW) | 1.5 | $127M | 871k | 145.57 | |
| Anthem (ELV) | 1.5 | $127M | 532k | 238.03 | |
| Alnylam Pharmaceuticals (ALNY) | 1.5 | $125M | 1.3M | 98.49 | |
| Thermo Fisher Scientific (TMO) | 1.4 | $121M | 584k | 207.14 | |
| DaVita (DVA) | 1.4 | $117M | 1.7M | 69.44 | |
| Immunomedics | 1.4 | $117M | 4.9M | 23.67 | |
| Agilent Technologies Inc C ommon (A) | 1.4 | $117M | 1.9M | 61.84 | |
| Amicus Therapeutics (FOLD) | 1.3 | $111M | 7.1M | 15.62 | |
| Clovis Oncology | 1.3 | $111M | 2.4M | 45.47 | |
| Dentsply Sirona (XRAY) | 1.2 | $105M | 2.4M | 43.77 | |
| Nevro (NVRO) | 1.2 | $101M | 1.3M | 79.85 | |
| Audentes Therapeutics | 1.2 | $100M | 2.6M | 38.21 | |
| Loxo Oncology | 1.1 | $93M | 538k | 173.48 | |
| Select Medical Holdings Corporation (SEM) | 1.1 | $92M | 5.1M | 18.15 | |
| Johnson & Johnson (JNJ) | 1.1 | $92M | 756k | 121.34 | |
| Inspire Med Sys (INSP) | 1.0 | $87M | 2.4M | 35.66 | |
| Array BioPharma | 1.0 | $82M | 4.9M | 16.78 | |
| Illumina (ILMN) | 0.9 | $80M | 285k | 279.29 | |
| Deciphera Pharmaceuticals | 0.9 | $79M | 2.0M | 39.35 | |
| Bluebird Bio (BLUE) | 0.9 | $77M | 488k | 156.95 | |
| Iovance Biotherapeutics (IOVA) | 0.8 | $71M | 5.5M | 12.80 | |
| Insmed (INSM) | 0.8 | $69M | 2.9M | 23.65 | |
| ACADIA Pharmaceuticals (ACAD) | 0.8 | $65M | 4.3M | 15.27 | |
| Corvus Pharmaceuticals (CRVS) | 0.8 | $66M | 6.0M | 10.98 | |
| Viewray (VRAYQ) | 0.8 | $66M | 9.5M | 6.92 | |
| Rhythm Pharmaceuticals (RYTM) | 0.8 | $65M | 2.1M | 31.26 | |
| Shire | 0.7 | $60M | 357k | 168.80 | |
| Sarepta Therapeutics (SRPT) | 0.7 | $60M | 453k | 132.18 | |
| Ironwood Pharmaceuticals (IRWD) | 0.7 | $59M | 3.1M | 19.12 | |
| Intuitive Surgical (ISRG) | 0.6 | $53M | 111k | 478.48 | |
| Universal Health Services (UHS) | 0.6 | $52M | 463k | 111.44 | |
| Teleflex Incorporated (TFX) | 0.6 | $51M | 190k | 268.21 | |
| Heron Therapeutics (HRTX) | 0.6 | $51M | 1.3M | 38.85 | |
| Xtant Med Hldgs (XTNT) | 0.6 | $51M | 9.2M | 5.55 | |
| Argenx Se (ARGX) | 0.6 | $50M | 599k | 82.86 | |
| Kala Pharmaceuticals | 0.6 | $47M | 3.4M | 13.73 | |
| Galapagos Nv- (GLPG) | 0.5 | $45M | 487k | 92.18 | |
| Restorbio | 0.5 | $44M | 4.8M | 9.15 | |
| eHealth (EHTH) | 0.5 | $41M | 1.8M | 22.10 | |
| Beigene | 0.5 | $40M | 261k | 153.73 | |
| Obseva Sa | 0.5 | $39M | 2.6M | 15.14 | |
| Mednax (MD) | 0.5 | $37M | 863k | 43.28 | |
| Zai Lab (ZLAB) | 0.5 | $38M | 1.6M | 23.25 | |
| CIGNA Corporation | 0.4 | $37M | 215k | 169.95 | |
| Tandem Diabetes Care (TNDM) | 0.4 | $37M | 1.7M | 22.02 | |
| Exelixis (EXEL) | 0.4 | $36M | 1.7M | 21.52 | |
| Pfizer (PFE) | 0.4 | $36M | 982k | 36.28 | |
| UnitedHealth (UNH) | 0.4 | $30M | 123k | 245.34 | |
| Incyte Corporation (INCY) | 0.3 | $29M | 438k | 67.00 | |
| Crispr Therapeutics (CRSP) | 0.3 | $29M | 496k | 58.76 | |
| Verrica Pharmaceuticals (VRCA) | 0.3 | $29M | 1.5M | 19.73 | |
| ImmunoGen | 0.3 | $28M | 2.9M | 9.73 | |
| Assembly Biosciences | 0.3 | $28M | 721k | 39.21 | |
| Gilead Sciences (GILD) | 0.3 | $26M | 365k | 70.84 | |
| LifePoint Hospitals | 0.3 | $25M | 513k | 48.80 | |
| Insys Therapeutics | 0.3 | $25M | 3.5M | 7.24 | |
| Cti Biopharma | 0.3 | $25M | 5.0M | 4.98 | |
| Alpine Immune Sciences | 0.3 | $25M | 3.3M | 7.57 | |
| Abbott Laboratories (ABT) | 0.3 | $24M | 394k | 60.99 | |
| Stryker Corporation (SYK) | 0.3 | $24M | 143k | 168.86 | |
| Magellan Health Services | 0.3 | $24M | 251k | 95.95 | |
| Hca Holdings (HCA) | 0.3 | $24M | 237k | 102.60 | |
| Intellia Therapeutics (NTLA) | 0.3 | $24M | 876k | 27.36 | |
| Selecta Biosciences | 0.3 | $24M | 1.8M | 13.25 | |
| Insmed Inc convertible security | 0.3 | $24M | 27M | 0.92 | |
| Amgen (AMGN) | 0.3 | $23M | 124k | 184.59 | |
| Radius Health | 0.3 | $23M | 763k | 29.47 | |
| Humana (HUM) | 0.3 | $22M | 73k | 297.63 | |
| Aerpio Pharmaceuticals | 0.3 | $22M | 5.2M | 4.15 | |
| Sinovac Biotech | 0.2 | $21M | 2.8M | 7.46 | |
| Coherus Biosciences (CHRS) | 0.2 | $21M | 1.5M | 14.00 | |
| Foamix Pharmaceuticals | 0.2 | $20M | 4.0M | 5.01 | |
| Global Blood Therapeutics In | 0.2 | $20M | 447k | 45.20 | |
| Aeglea Biotherapeutics | 0.2 | $20M | 1.9M | 10.58 | |
| Synlogic | 0.2 | $20M | 2.0M | 9.83 | |
| K2m Group Holdings | 0.2 | $19M | 843k | 22.50 | |
| Steadymed | 0.2 | $19M | 4.2M | 4.50 | |
| Scpharmaceuticals (SCPH) | 0.2 | $19M | 3.4M | 5.66 | |
| Natera (NTRA) | 0.2 | $19M | 984k | 18.82 | |
| Novus Therapeutics | 0.2 | $18M | 2.5M | 7.00 | |
| Verona Pharma Plc ads (VRNA) | 0.2 | $17M | 1.3M | 13.66 | |
| Pieris Pharmaceuticals | 0.2 | $16M | 3.1M | 5.07 | |
| Novo Nordisk A/S (NVO) | 0.2 | $15M | 330k | 46.12 | |
| Rocket Pharmaceuticals (RCKT) | 0.2 | $15M | 775k | 19.63 | |
| Amedisys (AMED) | 0.2 | $15M | 171k | 85.46 | |
| BioMarin Pharmaceutical (BMRN) | 0.2 | $14M | 147k | 94.20 | |
| Neurocrine Biosciences (NBIX) | 0.2 | $14M | 138k | 98.24 | |
| Nabriva Therapeutics | 0.2 | $14M | 3.9M | 3.48 | |
| Tenet Healthcare Corporation (THC) | 0.1 | $13M | 373k | 33.57 | |
| Triple-S Management | 0.1 | $11M | 291k | 39.06 | |
| Invitae (NVTAQ) | 0.1 | $11M | 1.5M | 7.35 | |
| Wright Medical Group Rtsn V | 0.1 | $11M | 8.7M | 1.28 | |
| Aegerion Pharmaceuticals 2% Du cvbond | 0.1 | $9.8M | 15M | 0.65 | |
| D Fluidigm Corp Del (LAB) | 0.1 | $9.4M | 1.6M | 5.96 | |
| Proqr Thrapeutics N V shs euro (PRQR) | 0.1 | $9.5M | 1.3M | 7.30 | |
| Dermira | 0.1 | $9.5M | 1.0M | 9.20 | |
| Fluidigm Corporation convertible cor | 0.1 | $8.1M | 10M | 0.81 | |
| Athenex | 0.1 | $8.0M | 430k | 18.66 | |
| Dbv Technologies S A | 0.1 | $7.9M | 411k | 19.29 | |
| Adaptimmune Therapeutics (ADAP) | 0.1 | $7.9M | 667k | 11.87 | |
| Inotek Pharmaceuticals 5.75% Cb 08/01/2021-registe bond | 0.1 | $7.2M | 7.0M | 1.03 | |
| Avrobio Ord (AVRO) | 0.1 | $7.1M | 250k | 28.56 | |
| Arsanis | 0.1 | $6.8M | 1.9M | 3.63 | |
| Electrocore | 0.1 | $6.6M | 398k | 16.51 | |
| Alkermes (ALKS) | 0.1 | $6.0M | 145k | 41.16 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $5.8M | 635k | 9.20 | |
| Redhill Biopharma Ltd cmn | 0.1 | $4.8M | 565k | 8.53 | |
| Ultragenyx Pharmaceutical (RARE) | 0.1 | $5.2M | 68k | 76.87 | |
| Marinus Pharmaceuticals | 0.1 | $4.0M | 568k | 7.07 | |
| Neuronetics (STIM) | 0.1 | $4.0M | 150k | 26.61 | |
| Akorn | 0.0 | $3.3M | 200k | 16.59 | |
| Tesaro | 0.0 | $3.0M | 67k | 44.47 | |
| Syndax Pharmaceuticals (SNDX) | 0.0 | $3.1M | 437k | 7.02 | |
| Sierra Oncology | 0.0 | $3.8M | 1.3M | 2.96 | |
| Orthopediatrics Corp. (KIDS) | 0.0 | $3.6M | 137k | 26.64 | |
| Gw Pharmaceuticals Plc ads | 0.0 | $2.9M | 21k | 139.52 | |
| Adamas Pharmaceuticals | 0.0 | $2.6M | 100k | 25.83 | |
| Biolinerx Ltd-spons | 0.0 | $924k | 1.0M | 0.89 | |
| Biomarin Pharmaceutical Inc note 0.750%10/1 | 0.0 | $530k | 500k | 1.06 | |
| Biomarin Pharmaceutical Inc note 1.500%10/1 | 0.0 | $590k | 500k | 1.18 | |
| Recro Pharma | 0.0 | $539k | 107k | 5.02 | |
| Aurinia Pharmaceuticals (AUPH) | 0.0 | $943k | 167k | 5.63 | |
| Affimed Therapeutics B V | 0.0 | $539k | 327k | 1.65 | |
| Alimera Sciences | 0.0 | $245k | 250k | 0.98 | |
| Medigus Ltd sponsord | 0.0 | $74k | 60k | 1.23 |
